Precision medicine is ushering in rapid changes in the medical industry, with technological advances in both Bioscience (e.g., advances in new targeted therapies, genomics and other 'omics') and Technology (e.g., improvements in artificial intelligence for treatment selection). The influx of capital and talents has prompted the commercialization and industrialization of precision medicine in drug research, gene sequencing, mobile medicine and other fields. Although there have been major innovations related to products in the field of health care, the speed of adapting to the path of precision medicine industrialization is still slow. How to turn its potential into reality and promote the innovation of medical business model has become an urgent problem.
In this session, we invite experts from the scientific and business circles to analyze the technological development and innovation of precision medicine as well as the industrialization path and challenges in China, and discuss the development trend and opportunities of precision medicine together.

Moderator

Ying SHEN, Financing Partner of KPMG China

Keynote Speech

-"Epigenetic stability of X chromosome in human embryonic stem cells"
Haoyi WANG, Principle Investigator, Group leader of Genome Engineering Technology, Institute of Zoology, Chinese Academy of Sciences, Member of Future Forum YOSIA
-"Application of high throughput sequencing in reproductive health"
Sijia LU, Co-Founder and CEO of Yikon Genomics
-"Application of precision medicine in clinical practice"
Bao ZHANG, Head of Department of Urology, Aerospace Center Hospital; Chief physician, Associate Professor of Peking University
-"Insight sharing of accompanying diagnosis in policy regulation and commercialization path"
Fang MEI, Consulting Partner of KPMG China